Similar articles for PMID: 31643821

Year	Number of Results
1981	1
1982	1
1985	1
1986	1
1987	2
1990	2
1991	3
1992	1
1994	2
1996	2
1998	1
1999	1
2001	1
2003	4
2004	4
2005	3
2006	6
2007	5
2008	2
2009	2
2010	3
2011	5
2012	25
2013	1
2014	3
2015	1
2016	3
2017	14
2018	2
2019	4
2020	12
2021	3
2022	3
2023	3
2025	0

1

[No authors listed] [No authors listed] 2017 Aug 17. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2017 Aug 17. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643821 Free Books & Documents. Review.

2

Azathioprine.

[No authors listed] [No authors listed] 2017 Aug 21. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2017 Aug 21. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643654 Free Books & Documents. Review.

3

Sustained effectiveness, safety and therapeutic drug monitoring of tioguanine in a cohort of 274 IBD patients intolerant for conventional therapies.

Simsek M, Deben DS, Horjus CS, Bénard MV, Lissenberg-Witte BI, Buiter HJC, van Luin M, Seinen ML, Mulder CJJ, Wong DR, de Boer NKH, van Bodegraven AA. Simsek M, et al. Aliment Pharmacol Ther. 2019 Jul;50(1):54-65. doi: 10.1111/apt.15280. Epub 2019 May 16. Aliment Pharmacol Ther. 2019. PMID: 31094013 Free PMC article.

4

Toxicity of 6-thioguanine: no hepatotoxicity in a series of IBD patients treated with long-term, low dose 6-thioguanine. Some evidence for dose or metabolite level dependent effects?

Gilissen LP, Derijks LJ, Driessen A, Bos LP, Hooymans PM, Stockbrügger RW, Engels LG. Gilissen LP, et al. Dig Liver Dis. 2007 Feb;39(2):156-9. doi: 10.1016/j.dld.2006.10.007. Epub 2006 Dec 26. Dig Liver Dis. 2007. PMID: 17188950

5

Thioguanine used in maintenance therapy of chronic myeloid leukaemia causes non-cirrhotic portal hypertension. Results from MRC CML. II. Trial comparing busulphan with busulphan and thioguanine.

Shepherd PC, Fooks J, Gray R, Allan NC. Shepherd PC, et al. Br J Haematol. 1991 Oct;79(2):185-92. doi: 10.1111/j.1365-2141.1991.tb04520.x. Br J Haematol. 1991. PMID: 1958475 Clinical Trial.

6

Early nodular hyperplasia of the liver occurring with inflammatory bowel diseases in association with thioguanine therapy.

Shastri S, Dubinsky MC, Fred Poordad F, Vasiliauskas EA, Geller SA. Shastri S, et al. Arch Pathol Lab Med. 2004 Jan;128(1):49-53. doi: 10.5858/2004-128-49-ENHOTL. Arch Pathol Lab Med. 2004. PMID: 14692812 Free article.

7

Effectiveness and safety of thioguanine as a maintenance therapy of inflammatory bowel disease: Systematic review, meta-analysis and meta-regression.

Jena A, Neelam PB, Telaprolu H, Mangipudi UK, Dutta U, Sebastian S, Sharma V. Jena A, et al. Clin Res Hepatol Gastroenterol. 2023 Aug;47(7):102155. doi: 10.1016/j.clinre.2023.102155. Epub 2023 Jun 8. Clin Res Hepatol Gastroenterol. 2023. PMID: 37301255 Review.

8

Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients.

de Boer NK, Zondervan PE, Gilissen LP, den Hartog G, Westerveld BD, Derijks LJ, Bloemena E, Engels LG, van Bodegraven AA, Mulder CJ. de Boer NK, et al. Dig Liver Dis. 2008 Feb;40(2):108-13. doi: 10.1016/j.dld.2007.10.013. Epub 2007 Dec 20. Dig Liver Dis. 2008. PMID: 18083079 Clinical Trial.

9

The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease.

van Asseldonk DP, Jharap B, Verheij J, den Hartog G, Westerveld DB, Becx MC, Russel MG, Engels LG, de Jong DJ, Witte BI, Mulder CJ, van Nieuwkerk CM, Bloemena E, de Boer NK, van Bodegraven AA. van Asseldonk DP, et al. Inflamm Bowel Dis. 2016 Sep;22(9):2112-20. doi: 10.1097/MIB.0000000000000869. Inflamm Bowel Dis. 2016. PMID: 27482972

10

Remission maintenance by tioguanine in chronic active Crohn's disease.

Herrlinger KR, Deibert P, Schwab M, Kreisel W, Fischer C, Fellermann K, Stange EF. Herrlinger KR, et al. Aliment Pharmacol Ther. 2003 Jun 15;17(12):1459-64. doi: 10.1046/j.1365-2036.2003.01590.x. Aliment Pharmacol Ther. 2003. PMID: 12823147

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 31643821

98 results

Results by year